| 1 |
Vendittelli PS, Botros B, Rosman HS, et al. Coronary artery embolism: two case reports and a review of the literature [J]. Am J Med Sci, 2019, 357(4): 333-337.
|
| 2 |
Meissner W, Lempert T, Saeuberlich-Knigge S, et al. Fatal embolic myocardial infarction after systemic thrombolysis for stroke [J]. Cerebrovascular Dis, 2006, 22(2-3): 213-214.
|
| 3 |
Sweta A, Sejal S, Prakash S, et al. Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger [J] Ann Indian And Neurol, 2010, 13(1): 64.
|
| 4 |
Yang CJ, Chen PC, Lin CS, et al. Thrombolytic therapy-associated acute myocardial infarction in patients with acute ischemic stroke: A treatment dilemma [J]. Am J Emerg Med, 2017, 35(5): 804.e1-804.e3.
|
| 5 |
Fitzek S, Fitzek C. A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic Stroke [J]. Neurologist, 2015, 20(3): 46-47.
|
| 6 |
Mannino M, Asciutto S, Terruso V, et al. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review [J]. J Stroke Cerebrovasc Dis, 2017, 26(6): e105-e107.
|
| 7 |
Wallace EL, Smyth SS. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study [J]. J Thromb Thrombolysis, 2012, 34(4): 548-551.
|
| 8 |
Almasi M, Razmeh S, Habibi AH, et al. Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction? [J]. Neurol Int, 2016, 8(2): 27-29.
|
| 9 |
Manea MM, Dragoş D, Stoica E, et al. Early ST-segment elevation acute myocardial infarction after thrombolytic therapy for acute ischemic stroke: A case report [J]. Medicine, 2018, 97(50): e13347.
|
| 10 |
Tanaka K, Ohara T, Ishigami A, et al. Fatal Multiple Systemic Emboli after Intravenous Thrombolysis for Cardioembolic Stroke [J]. J Stroke Cerebrovasc Dis, 2014, 23(2): 395-397.
|
| 11 |
Shibata T, Kawakami S, Noguchi T, et al. Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism [J]. Circulation, 2015, 132(4): 241-250.
|
| 12 |
Pitt A, Friesinger G, Ross R. Measurement of blood flow in the right and left coronary artery beds in humans and dogs using the 133Xenon technique [J]. Cardiovas Res, 1969, 3(1): 100-106.
|
| 13 |
Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association [J]. Stroke, 2017, 48(12): e343-e361.
|
| 14 |
Andreou I, Stone PH, Ikonomidis I, et al. Recurrent atherosclerosis complications as a mechanism for stent failure [J]. Hellenic J Cardiol, 2019, Apr 26. [Online ahead of print]
|
| 15 |
Mehdiratta M, Murphy C, Al-Harthi A, et al. Myocardial infarction following t-PA for acute stroke [J]. Can J Neurol Sci, 2007, 34(4): 417-420.
|
| 16 |
Hajsadeghi S, Rahbar MH, Iranpour A, et al. Dobutamine-in-duced takotsubo cardiomyopathy: a systematic review of the Literature and case report [J]. Anatol J Cardiol, 2018, 19(6): 412-416.
|
| 17 |
Ali A, Ahmad MQ, Malik MB, et al. Neurogenic stunned myocardium:a literature review [J]. Cureus, 2018, 10(8): e3129.
|
| 18 |
Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome [J]. Eur Heart J, 2018, 39(22): 2032-2062.
|
| 19 |
Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018 [J]. J Neurol, 2018, 51(9): 666-682.
|